GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » Net Income (Continuing Operations)

Avivagen (TSXV:VIV) Net Income (Continuing Operations) : C$-4.64 Mil (TTM As of Jul. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Avivagen Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Avivagen's Net Income (Continuing Operations) for the three months ended in Jul. 2023 was C$-0.93 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jul. 2023 was C$-4.64 Mil.


Avivagen Net Income (Continuing Operations) Historical Data

The historical data trend for Avivagen's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen Net Income (Continuing Operations) Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.83 -4.84 -4.75 -6.39 -6.07

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.90 -1.31 -1.15 -1.25 -0.93

Avivagen Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-4.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avivagen  (TSXV:VIV) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Avivagen Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Avivagen's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (TSXV:VIV) Business Description

Industry
Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Avivagen (TSXV:VIV) Headlines

From GuruFocus

1Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-10-2022

3Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 10-26-2022

A Trio of High Earnings Return Stocks

By Alberto Abaterusso Alberto Abaterusso 02-04-2021

1Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-12-2021

1Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-30-2022

2Q23 Results: Telef�nica Brasil S.A.

By PRNewswire 07-25-2023

1Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 06-29-2022

1Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 07-09-2022